Business Daily.
.
A+ R A-
Title Filter 
Display # 
# Article Title Author Hits
1201 ELIMOX - Partners Start Drug Development in Hyperoxaluria Australian Business 293
1202 ELIMOX - Partners startar läkemedelsutveckling inom hyperoxaluri Australian Business 363
1203 Hyalgan Injections are Now Being Offered by Total Health Australian Business 386
1204 KLOX Technologies gibt Genehmigung seiner innovativen Behandlung gegen Acne vulgaris in Kanada bekannt Australian Business 365
1205 Symposium visant à mettre en avant l'utilisation pratique d'un nouveau dosage des biomarqueurs dans le diagnostic de l'insuffisance rénale aiguë Australian Business 302
1206 Simposio destinado a resaltar la aplicación práctica de nuevos biomarcadores para el daño renal agudo Australian Business 398
1207 Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology Australian Business 384
1208 Simposio per evidenziare l'utilizzo pratico del nuovo test dei biomarcatori per grave insufficienza renale Australian Business 374
1209 IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum Australian Business 349
1210 New England Biolabs Intends to Appeal Court Decision in Lawsuit over Theft of its Trade Secrets Australian Business 276
1211 Nektar to Host Investor and Analyst R D Day in New York City Australian Business 335
1212 Weight Loss Surgery from Beverly Hills Physicians can Change Lives Australian Business 316
1213 Severely Obese Benefit from Multifaceted Approach to Weight Loss, Says Dr. Feiz Australian Business 362
1214 Stop Unnecessary Suffering by Detecting Common Indoor Allergens with PRO-LAB's® NEW Allergen Test Kit Australian Business 442
1215 Inova to Bring Healthplex to Akridge and Soave Enterprises' Loudoun Parkway Center Australian Business 366
1216 La Comisión Europea aprueba la ampliación en la indicación de Zonegran® (zonisamida) para su uso en niños con epilepsia parcial Australian Business 453
1217 La Commissione Europea approva l'indicazione per l'uso di Zonegran® (zonisamide) nei bambini con epilessia parziale Australian Business 386
1218 Eisai's Zonegran® (zonisamide) geregistreerd voor gebruik bij kinderen met partiële epilepsie in het VK en Nederland Australian Business 347
1219 Eisais Zonegran® (Zonisamid) für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen Australian Business 453
1220 Eisais Zonisamid für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen Australian Business 477

Page 61 of 96

Grow Your Business with Times Media
Business Daily Media